Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
IL-4 & Insulin Resistance in Patients With Atopic Dermatitis

The purpose of this study is to better understand the interactions between the innate immune system, in particular eosinophils, their secreted cytokines (interleukin-4), and metabolism in human health and disease states such as obesity and insulin resistance.

Accepts healthy volunteers
dupilumab
topical steroids
topical agents
body mass index
  • 0 views
  • 24 Oct, 2022
  • 1 location
Vitamin D Treatment Effect for Atopic Dermatitis in Children

A double-blind study to evaluate the role of human microbiome and vitamin D in the development of atopic dermatitis.

Accepts healthy volunteers
asthma
allergic rhinitis
urticaria
  • 0 views
  • 07 Oct, 2022
  • 1 location
Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

Prospective double-blinded placebo-controlled study, among adult patients suffering from moderate-to-severe atopic dermatitis (AD), insufficiently responsive to topical and systemic treatment

topical corticosteroid
corticosteroids
topical agents
atopy
  • 32 views
  • 04 Oct, 2022
  • 2 locations
Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement

This is a randomized, double blind, vehicle controlled Phase 2 study with a 4-week open label extension in adolescent and adult participants with atopic dermatitis and head and/or neck

  • 0 views
  • 04 Oct, 2022
  • 1 location
A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

To investigate the efficacy of 0.3% OPA-15406 ointment when administered twice daily for 4 weeks in infants younger than 2 years of age with Atopic Dermatitis

topical agents
  • 0 views
  • 04 Oct, 2022
  • 1 location
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis (BREEZE-AD-PEDS)

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

baricitinib
eczema
ly3009104
corticosteroids
topical agents
  • 142 views
  • 21 Oct, 2022
  • 10 locations
Apremilast 30 mg BID Combined With Dupilumab

Open label phase 2 investigational study of efficacy and safety of apremilast 30 mg BID in chronic atopic dermatitis when added to the FDA approved treatment dupilumab for atopic dermatitis that

dupilumab
vasectomy
atopy
treatment regimen
  • 4 views
  • 04 Oct, 2022
  • 1 location
A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis

CYP3A4/5 sensitive index substrates) in adult participants with moderateto- severe atopic dermatitis (AD).

eczema
topical agents
nemolizumab
calcineurin inhibitor
topical corticosteroid
  • 0 views
  • 07 Oct, 2022
  • 6 locations
Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

mild or moderate atopic dermatitis (AD) based on vIGA-AD. Cohort 2 and Cohort 3 will be performed in parallel and may commence after results are available from ARQ-151-212, a Phase 2 study evaluating

eczema
  • 42 views
  • 04 Oct, 2022
  • 8 locations
A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis

A multicenter, randomized, double-blind, placebo-controlled phase III clinical study of jaktinib hydrochloride tablets in the treatment of adult patients with moderate and severe atopic

  • 0 views
  • 07 Oct, 2022
  • 1 location